Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein

Nature Medicine

Volumn 5, Issue 12, 1999, Pages 1383-1389

  Herrera, Victoria L M ^a   Makrides, Savvas C ^a,b   Xie, Hou Xiang ^a   Adari, Hedy ^b   Krauss, Ronald M ^c   Ryan, Una S ^a,b   Ruiz Opazo, Nelson ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AVANT Immunotherapeutics Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SURVIVAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ARTERIOSCLEROSIS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY DISEASE; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LONGEVITY; MALE; MICE; PHENOTYPE; RATS; RATS, INBRED DAHL; SODIUM CHLORIDE; SPECIES SPECIFICITY;

EID: 0032735679     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/70956     Document Type: Article

References (48)

1. Multiple Risk Factor Intervention Trial Research Group. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev. Med. 15, 254-273 (1986).
2. Borhani, N.O. in Atherosclerosis Beyond Cholesterol 3-16 (Audio Visual Medical Marketing, New York, 1992).
3. Chobanian, A.V. & Alexander, R.W. Exacerbation of atherosclerosis by hypertension: potential mechanisms and clinical implications. Arch. Int. Med. 156, 1952-1956 (1996).
4. Chobanian, A.V. 1989 Corcoran Lecture: adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension 15, 666-674 (1990).
5. Chobanian, A.V. et al. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension 14, 203-209 (1989).
6. Brasen, I.H., Harsch, M. & Niendorf, A. Survival and cardiovascular pathology of heterozygous Watanabe heritable hyperlipidemic rabbits treated with pravastatin and probucol on a low-cholesterol (0.03%)-enriched diet. Virchows Arch. 432, 557-562 (1998).
7. Shiomi, M., Ito, T., Shiraishi, M. & Watanabe, Y. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis 96, 43-52 (1992).
8. Guyard-Dangeremont, V., Desrumaux, C., Gambert, P., Lallemant, C. & Lagrost, L. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 120, 517-525 (1998).
9. Moulin, P. Cholesteryl ester transfer protein: an enigmatic protein. Horm. Res. 45, 238-244 (1996).
10. Inazu, A. et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl. J. Med. 323, 1234-1238 (1990).
11. Yamashita, S. et al. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentrations and composition. Metabolism 40, 756-763 (1991).
12. Zhong, S.B. et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin Invest. 97, 2917-2923 (1996).
13. Marotti, K.R. et al. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364, 73-75 (1993).
14. Plump, A.S. et al. Increased atherosclerosis in ApoE and LDL receptor gene knockout mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler. Thromb. Vasc. Biol. 19, 1105-110 (1999).
15. Hayek, T. et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest. 96, 2071-2074 (1995).
16. Lee, R.T. & Libby, P. The unstable atheroma. Arterios. Throm. Vasc. Biol. 17, 1859-1867 (1997).
17. Herrera, V.L.M., Xie, H.X., Lopez, L.V., Schork, N.J. & Ruiz-Opazo, N. The α1 Na, K-ATPase gene is a susceptibility hypertension gene in the Dahl salt-sensitive rat. J. Clin. Invest. 102, 1102-1111 (1998).
18. Lefer, D.J. & Granger, D.N. Monocyte rolling in early atherogenesis: vital role in lesion development. Circ. Res. 11, 1353-1355 (1999).
19. Nakashima, Y., Raines, E.W., Plump, A.S., Breslow, J.L. & Ross, R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18, 842-851 (1998).
20. Nelken, N., Couglin, S., Gordon, D. & Wilcox J. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88, 1121-1127 (1991).
21. Shih, D.M., Welch, C. & Lusis, A.J. New insights into atherosclerosis from studies with mouse models. Mol. Med. Today (Elsevier Science Ltd.) 1, 364-372 (1995).
22. Jiang, X.C. et al. Down-regulation of messenger RNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. J. Biol. Chem. 268, 27406-27412 (1993).
23. Grass, D.S. et al. Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans. J. Lipid. Res. 36, 1082-1091 (1995).
24. Hayek, T. et al. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-1 genes in transgenic mice results in a profound CETP-mediated depression of high density cholesterol levels. J. Clin. Invest. 90, 505-510 (1992).
25. Foger, B., Ritsch, A., Doblinger, A., Wessels, H. & Patsch, J.R. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol: studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 16, 1430-1436 (1996).
26. Sechi, L.A. et al. Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats. Am. J. Hypertens. 10, 1223-1230 (1997).
27. Kitagawa, S., Yamaguchi, Y., Shinozuka, K, Kwon, Y.M. & Kunitomo, M. Dietary cholesterol enhances impaired endothelium-dependent relaxations in aortas of salt-induced hypertensive Dahl rats. Eur. J. Pharmacol 297, 71-76 (1995).
28. Reddick, R.L., Zhang, S.H. & Maeda, N. Atherosclerosis in mice lacking apoE. Evaluation of lesional development and progression. Arterioscler. Thromb. 14, 141-147 (1994).
29. Nakashima, Y., Plump, A.S., Raines, E.W., Breslow, J.L. & Ross, R. ApoE-deficient mice develop lesions of all phases of atherosclerosis through the arterial tree. Arterioscler. Thromb. 14, 133-140 (1994).
30. Ebara, T, Ramakrishnan, R, Steiner, C & Shacter, NS. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. J. Clin. Invest. 99, 2672-2681 (1997).
31. Paigen, B., Morrow, A., Brandon, C., Mitchell, D. & Holmes, P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57, 65-73 (1985).
32. Ong, G.L. & Mattes, M.J. Mouse strains with typical mammalian levels of complement activity. J. Immunol. Meth. 125, 147-158 (1991).
33. Torzewski, K., Bowyer, D.E., Waltenberger, J. & Fizsimmons, C. Processes in atherogenesis: complement activation. Atherosclerosis 132, 131-138. (1997).
34. Krauss, R.M. Triglycerides and atherogenic lipoproteins: Rational for lipid management. Am. J. Med. 105, 585-625 (1998).
35. Tropea, B.I. et al. Hypertension-enhanced monocyte adhesion in experimental atherosclerosis. J. Vasc. Surg. 23, 596-605 (1996).
36. Capers, Q. et al. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 30, 1397-1402 (1997).
37. Shioi, T. et al. Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ. Res. 81, 664-671 (1997).
38. O'Brien, K.D. et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J. Clin. Invest, 92, 945-951 (1993).
39. Schecter, A.D. et al. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J. Biol. Chem. 272, 28568-28573 (1997).
40. Buja, L.M. & Willerson, J.T. Role of inflammation in coronary plaque disruption. Circulation 89, 503-505 (1994).
41. Boyle, J.J. Association of coronary plaque rupture and atherosclerotic inflammation. J. Pathol. 181, 93-99 (1997).
42. Davies, H. & al-Tikriti, S. Coronary arterial pathology in the transplanted heart. Int. J. Cardiol. 25, 99-117 (1989).
43. Russell, P.S., Chase, C.M., Winn, H.J. & Colvin, R.B. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am. J. Pathol. 144, 260-274 (1994).
44. Atkinson, J.B. Accelerated arteriosclerosis after transplantation: the possible role of calcium channel blockers. Int. J. Cardiol. 62, S125-134 (1997).
45. Drayna, D. et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327, 632-634 (1987).
46. Zannis, V.I., Cole, S.F., Jackson, C, Kurnit, D.M. & Karathanasis, S.K. Distribution of apoA-I, apoC-II, apoC-III and apoE mRNA in human tissues. Time dependent induction of apoE mRNA by cultures of human monocyte-macrophages. Biochemistry 24, 4450-4455 (1985).
47. Adari, H., Xiang, X.H., Ruiz-Opazo, N., Herrera, V.L.M. & Makrides, S.C. in Vascular Endothelium: Pharmacologic and Genetic Manipulations (eds. Catravas, I.D., Callow, A.D. & Ryan, U.S.) 235-236 (NATO ASI Series, Plenum, New York, 1998).
48. Krauss, R.M., Grunfeld, C., Doerrler, W.T. & Feingold, K.R. Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition, Endocrinology 127, 1016-1021 (1990).